ArticleAnnals of medicine2026

JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17/Treg imbalance in a Sjögren's disease murine model.

Yanjun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.